Roundtable Discussions New

4.0 CME Credits

3 February 2020
Dubai World Trade Centre

The conference includes focused scientific group discussions on selected administration and technical topics in
the medical laboratory. These new roundtable discussions will allow participants to gain in depth knowledge, directly from a facilitator and share amongst other professionals the challenges and best practices in providing efficient diagnostic services. Delegates may choose to attend either the morning session or the afternoon session. Limited seats only. 

Morning session: 11:00 – 13:00
Afternoon session: 14:00 – 16:00     

Benefits of attending:

  • Assess advances in lab operations that will improve the turnaround time of the lab with fast reporting and accurate diagnosis 
  • Describe practical approaches avoid common pitfalls and improve quality 
  • Analyse quality improvement practices for safety 
  • Discuss better collaboration between the lab manager and lab staff
  • Appraise on how to eliminate testing deficiency to ensure consistency and accuracy in results
  • Discuss career development of a lab professional in the region

Activity director:

Dr Fadi W. Abdul-Karim, Professor Emeritus, Cleveland Clinic Lerner School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA

Facilitators:

Agatha Sto Domingo, QA Analyst, National Reference Laboratory, Abu Dhabi, UAE

Dr Basel Altrabulsi, Chief Medical Officer, National Reference Laboratory, Abu Dhabi, UAE

Bashir Ahmed, Supervisor, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE

Gerald Cox, Supervisor, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE

Dr Jay Murthy, Technical Director, National Reference Laboratory, Abu Dhabi, UAE

Lubna Rahim, Supervisor, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE

Manar Al Ramahi, Supervisor – Molecular Laboratory, National Reference Laboratory, Abu Dhabi, UAE

Nael Soudi, Chief Quality Officer, MedLabs Consultancy Group, Amman, Jordan

Dr Nashat Nafouri, Chair, Healthcare Interest Group, Executive Officer, Saudi Quality Council, Riyadh, KSA

Dr Rana Nabulsi, Consultant & Head of Quality, Pathology and Genetics Department, Dubai Health Authority, Dubai, UAE

Agatha Sto Domingo, QA Analyst, National Reference Laboratory, Abu Dhabi, UAE

Dr Basel Altrabulsi, Chief Medical Officer, National Reference Laboratory, Abu Dhabi, UAE

Bashir Ahmed, Supervisor, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE

Gerald Cox, Supervisor, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE

Dr Jay Murthy, Technical Director, National Reference Laboratory, Abu Dhabi, UAE

Lubna Rahim, Supervisor, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAEManar Al Ramahi

Supervisor
– Molecular Laboratory, National Reference Laboratory, Abu Dhabi, UAE

Nael Soudi, Chief Quality Officer, MedLabs Consultancy Group, Amman, Jordan

Dr Nashat Nafouri, Chair, Healthcare Interest Group, Executive Officer, Saudi Quality Council, Riyadh, KSA

Dr Rana Nabulsi, Consultant & Head of Quality, Pathology and Genetics Department, Dubai Health Authority, Dubai, UAE

Dr Sushma Umrao, Specialist, Clinical Pathology, Danat Al Emarat Hospital, Abu Dhabi, UAE

Dr Shweta Uppal, Head of Laboratory Services, Consultant, Anatomic & Clinical Pathology, Danat Al Emarat Hospital, Abu Dhabi, UAE

Dr Val Zvereff, Head of Molecular and Diagnostic Department, National Reference Laboratory, Abu Dhabi, UAE, Specialist, Clinical Pathology,
Danat Al Emarat Hospital, Abu Dhabi, UAE

Dr Shweta Uppal
, Head of Laboratory Services, Consultant, Anatomic & Clinical Pathology, Danat Al Emarat Hospital, Abu Dhabi, UAE

Dr Val Zvereff
, Head of Molecular and Diagnostic Department, National Reference Laboratory, Abu Dhabi, UAE